We are live on ! Find out more
FA

Fagan Associates Portfolio holdings

AUM $719M
1-Year Est. Return 26.65%
This Fund
S&P 500
This Quarter Est. Return
+11.4%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.69%
5 Year Est. Return
+107.31%
10 Year Est. Return
+467.14%
AUM
$308M
AUM Growth
+$49.3M
Cap. Flow
+$19.7M
Cap. Flow %
6.39%
Top 10 Hldgs %
38.56%
Holding
120
New
8
Increased
49
Reduced
44
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Financials 17.51%
3 Communication Services 11.28%
4 Consumer Discretionary 10.96%
5 Industrials 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBFS icon
101
Pioneer Bancorp
PBFS
$445M
$329K 0.11%
21,500
-500
-2% -$6.76K
PG icon
102
Procter & Gamble
PG
$343B
$315K 0.1%
2,523
EW icon
103
Edwards Lifesciences
EW
$47.6B
$307K 0.1%
3,945
CMCSA icon
104
Comcast
CMCSA
$79.1B
$299K 0.1%
6,643
+337
+5% +$15K
SDY icon
105
State Street SPDR S&P Dividend ETF
SDY
$21.9B
$287K 0.09%
2,666
-447
-14% -$46.9K
BAX icon
106
Baxter International
BAX
$11.6B
$272K 0.09%
3,250
D icon
107
Dominion Energy
D
$62.5B
$263K 0.09%
3,178
XLE icon
108
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$255K 0.08%
8,502
+4
+0% +$119
DUK icon
109
Duke Energy
DUK
$102B
$246K 0.08%
2,700
ED icon
110
Consolidated Edison
ED
$41.6B
$243K 0.08%
2,688
KO icon
111
Coca-Cola
KO
$354B
$234K 0.08%
4,230
PFE icon
112
Pfizer
PFE
$140B
$228K 0.07%
6,146
-132
-2% -$4.7K
ARKG icon
113
ARK Genomic Revolution ETF
ARKG
$1.51B
$227K 0.07%
+6,766
New +$215K
REGN icon
114
Regeneron Pharmaceuticals
REGN
$68.8B
$209K 0.07%
+557
New +$187K
AXP icon
115
American Express
AXP
$223B
$207K 0.07%
+1,660
New +$198K
TRST
116
Trustco Bank Corp NY
TRST
$977M
$100K 0.03%
+2,314
New +$99K
GD icon
117
General Dynamics
GD
$105B
-1,360
Closed -$249K
IBM icon
118
IBM
IBM
$202B
-22,194
Closed -$3.09M
ITOT icon
119
iShares Core S&P Total US Stock Market ETF
ITOT
$93.2B
-3,070
Closed -$206K
TTE icon
120
TotalEnergies
TTE
$193B
-6,240
Closed -$324K

Similar funds

Fagan Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Fagan Associates held 120 positions worth $308M, up 19% from $259M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Fagan Associates deployed $19.7M of net new capital in Q4 2019, opening 8 new positions and adding to 49 existing holdings. Its largest new stake was Goldman Sachs: 11,080 shares worth $2.55M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was lululemon athletica, an estimated $745K trimmed.

  • Fagan Associates's largest Q4 2019 buy was Goldman Sachs: 11,080 shares worth $2.55M.
  • Fagan Associates added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2019, an estimated $9.49M increase.
  • Fagan Associates's biggest Q4 2019 reduction was lululemon athletica, cutting an estimated $745K.
  • Fagan Associates fully exited IBM in Q4 2019, selling an estimated $3.09M.
  • Fagan Associates's ten largest holdings make up 39% of its $308M portfolio in Q4 2019.
  • Fagan Associates opened 8 new positions and closed 4 in Q4 2019.
  • Fagan Associates's portfolio value rose 19% quarter-over-quarter to $308M.

Based on Fagan Associates's 13F filing for Q4 2019, filed 7 Feb 2020.